DE69631468T2 - Nachweis von antikörpern gegen bakterielle antigene durch fluoreszenz-polarisation - Google Patents

Nachweis von antikörpern gegen bakterielle antigene durch fluoreszenz-polarisation Download PDF

Info

Publication number
DE69631468T2
DE69631468T2 DE69631468T DE69631468T DE69631468T2 DE 69631468 T2 DE69631468 T2 DE 69631468T2 DE 69631468 T DE69631468 T DE 69631468T DE 69631468 T DE69631468 T DE 69631468T DE 69631468 T2 DE69631468 T2 DE 69631468T2
Authority
DE
Germany
Prior art keywords
detection
antibodies against
bacterial antigens
against bacterial
fluorescent polarisation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69631468T
Other languages
English (en)
Other versions
DE69631468D1 (de
Inventor
E Jolley
H Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diachemix LLC
Original Assignee
Diachemix LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diachemix LLC filed Critical Diachemix LLC
Publication of DE69631468D1 publication Critical patent/DE69631468D1/de
Application granted granted Critical
Publication of DE69631468T2 publication Critical patent/DE69631468T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56916Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/5695Mycobacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/23Assays involving biological materials from specific organisms or of a specific nature from bacteria from Brucella (G)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50Lipopolysaccharides; LPS
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69631468T 1995-08-28 1996-08-28 Nachweis von antikörpern gegen bakterielle antigene durch fluoreszenz-polarisation Expired - Lifetime DE69631468T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/520,313 US5976820A (en) 1995-08-28 1995-08-28 Detection of antibodies to bacterial antigens by flourescence polarization
PCT/US1996/014860 WO1997008559A1 (en) 1995-08-28 1996-08-28 Detection of antibodies to bacterial antigens by fluorescence polarization

Publications (2)

Publication Number Publication Date
DE69631468D1 DE69631468D1 (de) 2004-03-11
DE69631468T2 true DE69631468T2 (de) 2004-10-07

Family

ID=24072066

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631468T Expired - Lifetime DE69631468T2 (de) 1995-08-28 1996-08-28 Nachweis von antikörpern gegen bakterielle antigene durch fluoreszenz-polarisation

Country Status (6)

Country Link
US (2) US5976820A (de)
EP (1) EP0788605B1 (de)
DE (1) DE69631468T2 (de)
ES (1) ES2215197T3 (de)
PT (1) PT788605E (de)
WO (1) WO1997008559A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8196688B2 (en) 2007-08-16 2012-06-12 Zf Friedrichshafen Ag Method for carrying out a tractive-force interrupted shifting in a parallel hybrid vehicle
US8308605B2 (en) 2007-09-01 2012-11-13 Zf Friedrichshafen Ag Method for controlling and/or regulating a hybrid drive arrangement

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976820A (en) 1995-08-28 1999-11-02 Jolley; Michael E. Detection of antibodies to bacterial antigens by flourescence polarization
DE19842609C2 (de) * 1998-09-17 2000-09-21 Diagnostik Gmbh Leipzig Lab Salmonellenantigengemisch und Kit zur Bestimmung von Antikörpern gegen Salmonellen
US6350574B1 (en) 1998-09-23 2002-02-26 Ronald C. Montelaro Fluorescence polarization—based diagnostic assay for equine infectious anemia virus
DE10023051B4 (de) * 2000-05-11 2004-02-19 Roche Diagnostics Gmbh Verfahren zur Herstellung von Fluoresceinisothiocyanat-Sinistrin, dessen Verwendung und Fluoresceinisothiocyanat-Sinistrin enthaltende diagnostische Zubereitung
US6812036B2 (en) 2000-09-11 2004-11-02 Diachemix Llc Fluorescence polarization-based homogeneous assay for deoxynivalenol determination in grains
EP1881324B1 (de) 2000-09-11 2015-01-21 Diachemix LLC Polarisationsbasierter, homogener Fluoreszenz-Assay zur Bestimmung von Deoxynivalenol in Körnern
US6482601B1 (en) * 2000-09-11 2002-11-19 Diachemix Llc Fluorescence polarization-based homogeneous assay for fumonisin determination in grains
NO20006130D0 (no) * 2000-12-01 2000-12-01 Erling Sundrehagen Reagens og analysemetode
CN1245629C (zh) * 2001-07-13 2006-03-15 迪亚科密克斯公司 基于荧光偏振的黄曲霉素均相检测法及其试剂盒
MXPA04003981A (es) * 2001-10-31 2004-10-29 Diachemix Llc Ensayo de polarizacion por fluorescencia a base de peptido para deteccion de anticuerpos para mycobacterium bovis.
KR20050042042A (ko) * 2001-10-31 2005-05-04 디아체믹스 엘엘씨 형광 편광 기술을 이용하는 파라투베르쿨로시스에 대한신속한 혈청학적 테스트
US20040137525A1 (en) * 2002-10-16 2004-07-15 Jolley Michael E. Detection of salmonella cells by fluorescence polarization
US7408640B2 (en) * 2003-11-05 2008-08-05 The United States Of America As Represented By The Secretary Of The Navy Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids
WO2005054854A1 (en) * 2003-11-05 2005-06-16 The United States Of America As Represented By The Secretary Of The Navy Naval Medical Research Center Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids
EP1705485B1 (de) * 2005-03-23 2008-08-20 Roche Diagnostics GmbH Verfahren zur Bestimmung der Glucosekonzentration durch Fluoreszenzpolarisation
US20110098309A1 (en) * 2007-07-12 2011-04-28 Acumen Pharmaceuticals, Inc. Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds
US8962677B2 (en) * 2007-07-12 2015-02-24 Acumen Pharmaceuticals, Inc. Methods of restoring cognitive ability using non-peptidic compounds
US9006283B2 (en) * 2007-07-12 2015-04-14 Acumen Pharmaceuticals, Inc. Methods of modifying amyloid β oligomers using non-peptidic compounds
US9217024B2 (en) 2007-12-18 2015-12-22 Acumen Pharmaceuticals, Inc. ADDL receptor polypeptides, polynucleotides and host cells for recombinant production
US7850917B2 (en) * 2008-03-11 2010-12-14 Ortho-Clinical Diagnostics, Inc. Particle agglutination in a tip
US20090270269A1 (en) * 2008-04-28 2009-10-29 Ashok Kumar Nano-scale fluoro-biosensors exhibiting a low false alarm rate for rapid detection of biological contaminants
US20100015690A1 (en) 2008-07-16 2010-01-21 Ortho-Clinical Diagnostics, Inc. Use of fluid aspiration/dispensing tip as a microcentrifuge tube
EP2663338B1 (de) 2011-01-14 2024-03-06 Emory University Glukosebasierte oligosaccharide enthaltend ein positronenemittierendes radionuklid und deren verwendung in der bildgebung
CN102662049B (zh) * 2012-05-07 2014-03-26 清华大学 基于碳纳米材料的免疫分析方法
US9402925B2 (en) 2013-03-12 2016-08-02 The Board Of Trustees Of The Leland Stanford Junio Probes and methods of imaging a bacterial infection
GB201306882D0 (en) 2013-04-16 2013-05-29 Sec Dep For Environment Food & Rural Affairs Acting Through The Oligosaccharide
WO2016149522A1 (en) * 2015-03-18 2016-09-22 Bio-Rad Laboratories, Inc. Sample analysis systems and methods
EP3535276A2 (de) 2016-11-04 2019-09-11 The Secretary Of State For Environment, Food And Rural Affairs Gedeckte oligosaccharide mit sieben oder mehr einheiten von 4,6-dideoxy-4-acylamido-alpha-pyranose und konjugate davon als impfstoffe gegen infektionen durch brucella-organismen
CN106353496A (zh) * 2016-11-10 2017-01-25 中国兽医药品监察所 布鲁氏菌荧光偏振(fpa)检测试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1212051A (en) * 1984-03-02 1986-09-30 John W. Cherwonogrodzky Identification of brucella abortus and brucellosis infection
CA1336576C (en) * 1986-09-26 1995-08-08 Malcolm B. Perry Immunoassays for discriminating between brucellosis infections and vaccinations
GB8624253D0 (en) * 1986-10-09 1986-11-12 Harvey W Endotoxin assay
US4921878A (en) * 1987-06-05 1990-05-01 Pall Corporation Non-fluorescing, non-reflective polyamide for use in diagnostic testing
US5212298A (en) * 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5445935A (en) * 1992-11-23 1995-08-29 Royer; Catherine A. Quantitative detection of macromolecules with fluorescent oligonucleotides
DE4240056A1 (de) * 1992-11-28 1994-06-01 Boehringer Mannheim Gmbh Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper
US5610075A (en) * 1995-01-17 1997-03-11 Stahl-Rees; Marianne Competitive electrochemiluminescence assays for endotoxins using a ruthenium label
US5976820A (en) 1995-08-28 1999-11-02 Jolley; Michael E. Detection of antibodies to bacterial antigens by flourescence polarization

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8196688B2 (en) 2007-08-16 2012-06-12 Zf Friedrichshafen Ag Method for carrying out a tractive-force interrupted shifting in a parallel hybrid vehicle
US8308605B2 (en) 2007-09-01 2012-11-13 Zf Friedrichshafen Ag Method for controlling and/or regulating a hybrid drive arrangement

Also Published As

Publication number Publication date
ES2215197T3 (es) 2004-10-01
PT788605E (pt) 2004-06-30
DE69631468D1 (de) 2004-03-11
EP0788605A1 (de) 1997-08-13
EP0788605B1 (de) 2004-02-04
WO1997008559A1 (en) 1997-03-06
US5976820A (en) 1999-11-02
US6596546B1 (en) 2003-07-22

Similar Documents

Publication Publication Date Title
DE69631468D1 (de) Nachweiss von antikörper gegen bakterielle antigene durch fluoreszenz-polarisation
DE69636843D1 (de) Nachweis von Nukleinsäure-Änderungen
DE69434520D1 (de) Biotinylierung von proteinen
ATE384792T1 (de) Antikörpervarianten mit höheren bindungsaffinitäten im vergleich zu parentalen antikörpern
DE69612017T2 (de) Emulsion zur robusten erfassung von gasen
DE69936389D1 (de) Herstellung von motiv-spezifischen und kontextunabhängigen antikörpern unter verwendung von peptidbibliotheken als antigene
DE69614768D1 (de) Emulsionsspaltung durch Mikroorganismen
DE69425072T2 (de) Polyklonaler antikörper gegen pna/nukleinsäurekomplexe
DE69622776D1 (de) Von Multitasking gebrauch machendes Sortieren
DE69530078D1 (de) Antigen/antikörper spezifitätsaustauscher
FR2839555B1 (fr) Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
DE59505585D1 (de) Antigene und Antikörper zum Nachweis von Kollagen I
KR950009255A (ko) 피레트로이드계 화합물의 면역학적 검출방법, 합텐화합물, 합텐화합물 중간체, 면역원 및 항체
GB2307041B (en) Sheets,kits and methods for detecting antigens or antibodies
AU7113696A (en) Detection and quantitation of 8-oh-adenine using monoclonal antibodies
FI960167A (fi) Sydänlihaskuolion osoittaminen immuunimäärityksellä ja siihen sopivat vasta-aineet
DK1115746T3 (da) Antistoffer mod et antigen fra langerhansske celler hos pattedyr samt anvendelser deraf
DE69602155D1 (de) Verbesserung von Branntweinen
ATA203796A (de) Zementbeschleuniger zementbeschleuniger
DE59510146D1 (de) Antikörper für den Nachweis von Salmonellen
FR2728904B1 (fr) Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif
AU1917300A (en) Improved specificity in the detection of anti-rubella igm antibodies
FR2737209B1 (fr) Peptide capable d'etre reconnu par des anticorps reconnaissant l'antigene c33 du virus de l'hepatite c
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition